Artikkelit - Selaus asiasanan mukaan "vaccine"
Viitteet 1-13 / 13
-
Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals
INFLUENZA AND OTHER RESPIRATORY VIRUSES : 3 (2013) -
Childhood Bacterial Respiratory Diseases
PEDIATRIC INFECTIOUS DISEASE JOURNAL : 10 (2009) -
Cohort study design for estimating the effectiveness of seasonal influenza vaccines in real time based on register data: The Finnish example
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2020) -
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study
JOURNAL OF INFECTIOUS DISEASES (2024) -
Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial
PEDIATRIC INFECTIOUS DISEASE JOURNAL : 11 (2015) -
Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study
JOURNAL OF INFECTIOUS DISEASES (2024) -
Interleukin-10 gene promoter region polymorphisms are not associated with BCG osteitis in vaccinated infants
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE : 10 (23.10.2015) -
Molecular typing of Bordetella parapertussis isolates circulating in Pakistan
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY : 3 (2011) -
Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly
INFECTIOUS DISEASES : 5 (2017) -
Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months
JOURNAL OF INFECTIOUS DISEASES : 12 (2016) -
T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-up
FRONTIERS IN IMMUNOLOGY (2023) -
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE-a European initiative
EXPERT REVIEW OF VACCINES : 12 (2022)